- Intuitive Surgical recently announced plans to expand its Asia Pacific manufacturing footprint with a new facility in Penang, Malaysia, expected to start operations in 2028 and produce instruments and electromechanical devices for the da Vinci surgical system.
- This move adds a new production hub to Intuitive Surgical’s global network, potentially supporting regional supply resilience and closer alignment with hospitals adopting robotic-assisted surgery across Asia Pacific.
- We’ll now examine how building a Penang manufacturing hub may influence Intuitive Surgical’s investment narrative and long-term growth priorities.
Find 50 companies with promising cash flow potential yet trading below their fair value.
Intuitive Surgical Investment Narrative Recap
To own Intuitive Surgical, you need to believe robotic-assisted surgery will remain embedded in hospital care and keep supporting high-margin instrument and service revenue. The Penang facility mainly reinforces supply resilience and regional access; it does not materially change the near-term focus on procedure volumes and managing ongoing product recalls, which remain key catalysts and operational risks for the business.
The most relevant recent update alongside the Penang announcement is Intuitive Surgical’s Q2 2026 earnings, with revenue of US$2,892.3 million and net income of US$818.1 million. These results frame how added manufacturing capacity could intersect with future demand in Asia Pacific, while investors continue to watch how recalls, hospital budgets, and pricing pressures shape the trajectory of system placements and recurring revenue.
Yet in contrast, investors should also be aware of how rising tariffs and trade tensions could...
Read the full narrative on Intuitive Surgical (it's free!)
Intuitive Surgical's narrative projects $15.6 billion revenue and $4.7 billion earnings by 2029.
Uncover how Intuitive Surgical's forecasts yield a $501.73 fair value, a 34% upside to its current price.
Exploring Other Perspectives
Some of the most optimistic analysts were already modeling revenue of about US$17.2 billion and earnings of roughly US$4.9 billion by 2029, so this new Penang capacity and the risk of rising tariffs might shift how you weigh those bullish expectations against more cautious views.
Explore 11 other fair value estimates on Intuitive Surgical - why the stock might be worth as much as 68% more than the current price!
Reach Your Own Conclusion
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Intuitive Surgical research is our analysis highlighting 3 key rewards that could impact your investment decision.
- Our free Intuitive Surgical research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Intuitive Surgical's overall financial health at a glance.
Interested In Other Possibilities?
Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:
- Capitalize on the AI infrastructure supercycle with our selection of the 54 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
- The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 17 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
- Rare earth metals are the new gold rush. Find out which 28 stocks are leading the charge.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com